E neil moore (187 résultats)

Paperback. Etat : As New. No Jacket. Pages are clean and are not marred by notes or folds of any kind. ~ ThriftBooks: Read More, Spend Less.

Soft cover. Etat : Very Good. 28 pages. Illustrated. W R Bawden "The Horsey Man" / Moore Raymond Seeing Stars" / Chas. E Lewins "Somebody Bubbled!" / Argent Neil "A Smart Girl" /D H Cadman "Medal for Fred" / A N Ford "Civvy Street Strategy" (SL#121).

Etat : New.

Etat : As New. Unread book in perfect condition.

Soft cover. Etat : Very Good. 96 pages. 3 John Saul Pharmacists and other Alfreds 9 Harriet Moore To get back to my body 12 Marianne Burton Kierkegaard s Cupboard 13 Giovanna Iozzi / Hannah Cooper The Half-Pigs 22 Carrie Etter Plait 23 Mark Strand Here 30 Natacha Bryan Blue Gown (an account from Sister Dixon) 32 Avital Gad-Cykman Barren 34 Edward Doegar Voyeurism 35 William Wootten Snowbound 36 Interview with Patrick Strzelec 46 Matthew Landrum Snow For Yvonne 48 David Henry Brown Jr Yellow Girl 50 Neil Rathmell Wasting Time 52 Roisin Dunnett The Bitter in the Sweet 58 George Jackson St. Pancras Old Church 60 Seán Hewitt from Oak 62 E. Kristin Anderson Frame 63 Lydia Macpherson America 64 Susanne Stich / Sean McSorley Portland 74 Lee Maelzer Fortune s Entrails 84 Jacqueline Sullivan Journal: War and Peace 86 Alexandra Strnad August 88 Joey Connolly I Am Positioned 89 Phoebe Stuckes Three Spells 90 Alex MacDonald Don t Let Me Down, Important Spectacle 91 Clare Pollard The Last Poem of Rabia Balkhi, Written in Blood on Her Bathroom Walls After Her Veins Were Cut by Her Brother. 92 Ariel Dawn Among the Paintings 93 Erica McAlpine Bucket 96 Jordie Oetken Untitled, 2013 Artwork on cover by Patrick Strzelec.…

Etat : New.

Etat : As New. Unread book in perfect condition.

Etat : New.

Etat : New.

Paperback or Softback. Etat : New. The Evaluation of New Antiarrhythmic Drugs: Proceedings of the Symposium on How to Evaluate a New Antiarrhythmic Drug: The Evaluation of New Antiarrhy. Book.

Etat : New.

Etat : As New. Unread book in perfect condition.

Etat : As New. Unread book in perfect condition.

Etat : New.

Etat : As New. Unread book in perfect condition.

Etat : New.

Etat : New.

Etat : As New. Unread book in perfect condition.

Etat : As New. Unread book in perfect condition.

Etat : New. pp. 340.

Etat : New. pp. 424.

Paperback. Etat : Brand New. 340 pages. 9.25x6.10x0.77 inches. In Stock.

Paperback. Etat : Brand New. 424 pages. 9.25x6.10x0.96 inches. In Stock.

Etat : New.

Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - With the beginning of the 1980's it was becoming increasingly evident that the lack of approval of new cardiovascular agents for use by clinicians in the United States for the treatment of cardiovascular disorders was becoming a problem. Patients requiring medical therapy for hypertension, angina pectoris, arrhythmias, congestive heart failure, and vasospastic disorders of the coronary arteries could receive in the United States only a small number of the drugs available to physicians in the rest of the world. In fact, as the 1980's began, there was only one available beta blocking agent released by The Food and Drug Administration; and even as of this writing, no oral calcium antagonist agent. This lag, in part, has been due to the confusion of proper and expeditious methods to define safety and efficacy of such agents so that the United States regulatory agency (Food and Drug Administration) could approve the use of such agents by clinicians. The vast number of new beta blocker and calcium antagonist agents being developed, as well as the long-term use abroad of many new drugs, has raised important questions as to how relative safety and efficacy of such agents can be determined to facilitate availability in the United States.…

Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Thus, there are now several chronic canine myocardial infarction ventricular tachyarrhythmia models which are available for the evaluation of new antiarrhythmic drugs (Table I). The available models fulfill many, but not all of the requirements for an ideal chronic arrhythmia model (Table 11). The sustained arrhythmias initiated in these models using programmed pacing presumably have the same localized reentrant mechanism that characterizes chronic human myocardial infarction and chronic coronary 26 artery disease. However, these models are not suitable for determining whether a new drug will abolish spontaneous ly-occurring PVCs. In addition, these models are of unproven value in the study of acute spontaneously occurring sudden death; although recently initiated, provocative work may shed further light on this subject. Most importantly, the available models do seem well-suited to the evaluation of new drugs intended for use in chronic coronary artery disease patients at risk for sustained reentrant ventricular tachycardia or VF. Notably, the results of preliminary electropharmacologic studies in these canine models parallel closely those findings reported in human patients with sustained life-threatening ventricu lar tachyarrhythmias (Table Ill). Therefore, increased use of these chronic models for new antiarrhythmic drug testing is strongly recommended. TABLE II Ideal vs Available Chronic Canine - Arrhythmia Models Ideal Available 1. (a) Arrhythmia mechanism comparable to Yes patients with chronic CAD: Reentry (b) Pathophysiology similar (e. g. , atherogenic CAD) No 2. Susceptible to: (a) spontaneous PVCs No l No (b) spontaneous VT/VF (c) inducible VT/VF Yes 3.…

Etat : New. Satisfaction Guaranteed or your money back.

Etat : New.

Etat : New.

Etat : As New. Unread book in perfect condition.